Traxler, EA, Komar, C, Saari, M, Thrasher, M, Qin, K, Khandros, E, Hotan, Q, Abdulmalik, O, Shao, C, Chen, Q, Minn, AJ, Keller, CA, Shi, J, Blobel, GA. Genome-scale CRISPR-Cas12a screen identifies novel fetal hemoglobin regulators. , The American Society of Hematology Annual Meeting, San Diego, CA.: 2023
Sayani, FA, Liu, M, Frimpong, Y, Peslak, SA, Traxler, EA, Cohen, J, Russell, JE, Kwiatkowski, JL. Adults with transfusion-dependent thalassemia have variable clinical profiles depending on where they receive care: thalassemia treatment center vs community. , The American Society of Hematology Annual Meeting, San Diego, CA.: 2023
Cheng, A, Traxler, EA, Peslak, SA, Cohen, J, Russell, JE, Sayani, FA. Patients with non-transfusion-dependent thalassemia may evolve to transfusion-dependent thalassemia in adulthood. , The American Society of Hematology Annual Meeting, San Diego, CA.: 2023
Peslak, SA, Abbas, T, Khandros, E, Traxler, EA, Abdulmalik, O, Giardine, B, Keller, CA, Hardison, R, Shi, J, Blobel, GA. Protein phosphatase 6 complex: novel regulator of fetal hemoglobin and potential therapeutic target in sickle cell disease. , The American Society of Hematology Annual Meeting, San Diego, CA.: 2023
Elizabeth A Traxler, Elizabeth O Hexner. Running interferon interference in treating PV/ET: meeting unmet needs , Hematology Am Soc Hematol Educ Program
: 2021,463-468
Ji, X, Jha A, Humenik J, Ghanem LR, Kromer A, Duncan-Lewis C, Traxler E, Weiss MJ, Barash Y, Liebhaber SA. RNA-binding proteins PCBP1 and PCBP2 are critical determinants of murine erythropoiesis. , Mol Cell Biol
, 41(9): 2021,e0066820.
Halaby R, Cuker A, Yui J, Matthews A, Ishaaya E, Traxler E, Domenico C, Cooper T, Tierney A, Niami P, van der Rijst N, Adusumalli S, Gutsche J, Giri J, Pugliese S, Hecht THE, Pishko AM. Bleeding risk by intensity of anticoagulation in critically ill patients with COVID-19: a retrospective cohort study. , J Thromb Haemost
, 19(6): 2021,1533-1545
Traxler EA, Thom CS, Yao Y, Paralkar V, Weiss MJ. Nonspecific inhibition of erythropoiesis by short hairpin RNAs. , Blood
, 131(24): 2018,2733-2736
Traxler EA, Yao Y, Wang YD, Woodard KJ, Kurita R, Nakamura Y, Hughes JR, Hardison RC, Blobel GA, Li C, Weiss MJ. A genome-editing strategy to treat -hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition. , Nat Med
, 22(9): 2016,987-90
Bui HM, Enis D, Robcuic MR, Nurmi HJ, Cohen J, Chen M, Yang Y, Dhillon V, Johnson K, Zhang H, Kirkpatrick R, Traxler E, Anisimov A, Alitalo K, Kahn ML. Anisimov A, Alitalo K, Kahn ML. Proteolytic activation defines distinct lymphangiogenic mechanisms for VEGFC and VEGFD. , J Clin Invest
, 126(6): 2016,2167-80
